← Insider buys
RARE

Ultragenyx Pharmaceutical Inc. · Healthcare

EVP and Chief Commercial Officer Erik Harris sold $166K of Ultragenyx Pharmaceutical Inc.

Sold$165,796
$45.25Price
3,664Shares
−6%Stake

What RARE did after the filing

Filed Mar 3Copier in Mar 6
The stock from Mon, Mar 6 open, $45.37
−9.7%
S&P 500, same days
+2.7%

Measured over 30 trading days, to the Apr 18 close.

Traded Wed, Mar 1. Filed Fri, Mar 3, 7:51 PM ET, after the close. Returns use the Mar 6 open and the Apr 18 close. Not investment advice.